Michael Matson
Stock Analyst at Needham
(2.20)
# 2,654
Out of 5,182 analysts
23
Total ratings
60%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $135.52 | +212.13% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $7.35 | +1,124.49% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $66.74 | -20.59% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $90.74 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $217.14 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $58.45 | - | 1 | Dec 8, 2017 | |
| KTWO K2 Capital Acquisition | Downgrades: Buy | n/a | $9.96 | - | 2 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $61.29 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $321.43 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $9.05 | - | 1 | Mar 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $77.45 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.18 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.22 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1,002.35 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $135.52
Upside: +212.13%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $7.35
Upside: +1,124.49%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $66.74
Upside: -20.59%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $90.74
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $217.14
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $58.45
Upside: -
K2 Capital Acquisition
Dec 8, 2017
Downgrades: Buy
Price Target: n/a
Current: $9.96
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $61.29
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $321.43
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $9.05
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $77.45
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.18
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $5.22
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $1,002.35
Upside: -